COVID-19 medical costs drag Aetna’s commercial business, but CVS still posts $1.6B in Q3 profit

Though the pandemic continues to stress CVS’ payer segment, drugstores continue to benefit from COVID-19 testing and vaccinations, particularly as a greater number of employers begin to mandate the shots.